Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 106 (RN7SKP106) is a human genomic locus classified as a pseudogene of the 7SK small nuclear RNA gene family. Unlike the functional 7SK snRNA, which plays a central role in the regulation of transcription elongation through modulation of P-TEFb and has significant biological and disease relevance[1][2], RN7SKP106 is considered nonfunctional and does not produce a regulatory RNA product. It does not serve as a therapeutic target, biomarker, or disease-associated locus and has no known biological or pharmacological significance[3]. RN7SKP106 is a pseudogene, not a protein or regulatory RNA, and is therefore not a drug target or subject to pharmacological modulation. If you are interested in the biologically active **7SK small nuclear RNA (7SK snRNA)**, refer instead to "RN7SK," which is the functional molecule involved in transcriptional regulation[1][2].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 106 (RN7SKP106).